Q: Hi guys,
Do you think the regulatory hit that PJC.A took, regarding generic prescription drugs, in Quebec, could be a danger to Loblaws in provinces outside of Quebec?
Do you think its still ok to use the consensus $4.04 earnings per share in 2016, in determining value for Loblaws?
Thanks.
Do you think the regulatory hit that PJC.A took, regarding generic prescription drugs, in Quebec, could be a danger to Loblaws in provinces outside of Quebec?
Do you think its still ok to use the consensus $4.04 earnings per share in 2016, in determining value for Loblaws?
Thanks.